ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

XENE Xenon Pharmaceuticals Inc

37,00
0,00 (0,00%)
26 Juin 2024 - Fermé
Retardé de 15 minutes
Quarter End Juin 2022Sept 2022Déc 2022Mar 2023Juin 2023Sept 2023Déc 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Actif total 807,38M775,81M754,15M719,87M684,9M671,09M964,8M919,02M
Total de l'actif circulant 794,8M649,18M600,3M533,35M544,62M531,01M644,96M707,2M
Trésorerie et équivalents 369,99M103,49M57,24M69,51M64,55M99,57M148,64M58,9M
Total des actifs non courants 9,38M123,65M149,94M184,4M140,05M140,82M320,3M212,33M
Total des passifs 21,59M22,69M32,65M32,92M38,44M34,5M36,88M31,33M
Total des passifs courants 13,74M15,54M22,7M22,49M28,16M24,74M27,27M22,22M
Total des passifs non courants 7,85M7,16M9,95M10,43M10,28M9,76M9,6M9,1M
Capitaux propres ordinaire 1,06B1,06B1,07B1,07B1,08B1,12B1,44B1,44B
Bénéfices non distribués -408,2M-445,35M-482,75M-524,47M-571,94M-620,4M-665,14M-713,07M
Fin d'année 31 Décembre 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Actif total 67,49M46,12M122,43M147,7M189,19M572,01M754,15M964,8M
Total de l'actif circulant 65,68M44,82M121,44M144,87M181,78M559,02M600,3M644,96M
Trésorerie et équivalents 17,1M20,49M67,75M24,76M45,01M175,69M57,24M148,64M
Total des actifs non courants 63,9M35,93M103,3M91,98M171,36M550,03M721,5M927,92M
Total des passifs 3,59M10,19M19,13M55,72M17,83M21,97M32,65M36,88M
Total des passifs courants 3,52M4,08M4,12M43,38M14,78M14,32M22,7M27,27M
Total des passifs non courants 70k12,21M30,03M23,23M3,05M7,65M9,95M9,6M
Total des capitaux propres 63,9M35,93M103,3M91,98M171,36M550,03M721,5M927,92M
Capitaux propres ordinaire 173,25M173,84M273,66M301,98M405,48M790,9M1,07B1,44B
Bénéfices non distribués -143,67M-174,38M-208,88M-249,66M-278,49M-357,37M-482,75M-665,14M

Dernières Valeurs Consultées